Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

NCT02431429 · clinicaltrials.gov ↗

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucocutaneous Leishmaniasis

Interventions

DRUG: Miltefosine

Sponsor

Knight Therapeutics (USA) Inc